|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV040401235 |
003 |
DE-627 |
005 |
20230624073156.0 |
007 |
cr uuu---uuuuu |
008 |
180603s2017 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.pcd.2017.03.007
|2 doi
|
028 |
5 |
2 |
|a GBVA2017009000027.pica
|
035 |
|
|
|a (DE-627)ELV040401235
|
035 |
|
|
|a (ELSEVIER)S1751-9918(17)30048-7
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
|
|a 610
|
082 |
0 |
4 |
|a 610
|q DE-600
|
082 |
0 |
4 |
|a 630
|q VZ
|
082 |
0 |
4 |
|a 640
|q VZ
|
082 |
0 |
4 |
|a 590
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 600
|q VZ
|
084 |
|
|
|a 50.70
|2 bkl
|
100 |
1 |
|
|a Foguet-Boreu, Quintí
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Pharmacological control of diabetes and hypertension comorbidity in the elderly: A study of “real world” data
|
264 |
|
1 |
|c 2017
|
300 |
|
|
|a 12
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a • Real world data should be considered in developing Clinical Practice Guidelines. • Some of the drug combinations were associated with better control of diabetes and hypertension than others in the elderly population. • The effort to control diabetes and hypertension comorbidity would benefit from improved adherence to diabetes treatment.
|
650 |
|
7 |
|a ICD-10
|2 Elsevier
|
650 |
|
7 |
|a OR
|2 Elsevier
|
650 |
|
7 |
|a DDD
|2 Elsevier
|
650 |
|
7 |
|a PHC
|2 Elsevier
|
650 |
|
7 |
|a GCG
|2 Elsevier
|
650 |
|
7 |
|a IQR
|2 Elsevier
|
650 |
|
7 |
|a EHR
|2 Elsevier
|
650 |
|
7 |
|a BP
|2 Elsevier
|
650 |
|
7 |
|a MPR
|2 Elsevier
|
650 |
|
7 |
|a CCBs
|2 Elsevier
|
650 |
|
7 |
|a ATC
|2 Elsevier
|
650 |
|
7 |
|a SD
|2 Elsevier
|
650 |
|
7 |
|a PCG
|2 Elsevier
|
650 |
|
7 |
|a RCTs
|2 Elsevier
|
650 |
|
7 |
|a ACEi
|2 Elsevier
|
650 |
|
7 |
|a CPG
|2 Elsevier
|
650 |
|
7 |
|a SIDIAP-Q
|2 Elsevier
|
650 |
|
7 |
|a ARBs
|2 Elsevier
|
650 |
|
7 |
|a HbA1c
|2 Elsevier
|
650 |
|
7 |
|a CVR
|2 Elsevier
|
650 |
|
7 |
|a BMI
|2 Elsevier
|
700 |
1 |
|
|a Violán, Concepción
|4 oth
|
700 |
1 |
|
|a López Jiménez, Tomás
|4 oth
|
700 |
1 |
|
|a Pons-Vigués, Mariona
|4 oth
|
700 |
1 |
|
|a Rodríguez-Blanco, Teresa
|4 oth
|
700 |
1 |
|
|a Valderas, Jose M.
|4 oth
|
700 |
1 |
|
|a Guisado Clavero, Marina
|4 oth
|
700 |
1 |
|
|a Pujol-Ribera, Enriqueta
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier
|a David, Lauren A. ELSEVIER
|t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|d 2016
|g Amsterdam [u.a.]
|w (DE-627)ELV024210129
|
773 |
1 |
8 |
|g volume:11
|g year:2017
|g number:4
|g pages:348-359
|g extent:12
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.pcd.2017.03.007
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_72
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 50.70
|j Energie: Allgemeines
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 11
|j 2017
|e 4
|h 348-359
|g 12
|
953 |
|
|
|2 045F
|a 610
|